Miguel Foronda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Miguel Foronda has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Dogan
Memorial Sloan Kettering Cancer Center, New York, NY
49 shared publications - Andrea Schietinger
Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA
49 shared publications - Brian D. Greenstein
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA
49 shared publications - Caitlin J. Jones
Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York. 4
49 shared publications - Carl Campos
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. 1
49 shared publications - Daniel A. Navarrete
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York. 1
49 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Springer Nature in Nature Chemical Biology
A selective TNKS2 inhibitor for tumor-restricted WNT suppression
Hyperactive WNT signaling is a potent cancer driver but clinical translation of WNT inhibitors has been hampered by on-target toxicities. WNT signaling can be constrained through inhibition of the PARP-family enzymes tankyrase 1 (TNKS1) and TNKS2; however, existing TNKS inhibitors suppress WNT signaling in both tumor and healthy tissues. In this Article, we show that genomic loss of TNKS1 on chromosome 8p creates a collateral vulnerability that drives a tumor-restricted dependency on TNKS2 for cellular TNKS activity. Through structure-guided design, we identify a flexible loop in TNKS2 that can be exploited to enable TNKS2-selective drug targeting and we generate a first-in-class TNKS2 inhibitor to drive selective WNT inhibition in TNKS1-deficient cell and organoid models. This work demonstrates a targetable cancer-specific vulnerability in multiple cancer types, providing a new approach for WNT-targeted therapies.
- 2 November 2026
- Published by Springer Nature in Nature Chemical Biology
Open AccessA selective TNKS2 inhibitor for tumor-restricted WNT suppression
Hyperactive WNT signaling is a potent cancer driver but clinical translation of WNT inhibitors has been hampered by on-target toxicities. WNT signaling can be constrained through inhibition of the PARP-family enzymes tankyrase 1 (TNKS1) and TNKS2; however, existing TNKS inhibitors suppress WNT signaling in both tumor and healthy tissues. In this Article, we show that genomic loss of TNKS1 on chromosome 8p creates a collateral vulnerability that drives a tumor-restricted dependency on TNKS2 for cellular TNKS activity. Through structure-guided design, we identify a flexible loop in TNKS2 that can be exploited to enable TNKS2-selective drug targeting and we generate a first-in-class TNKS2 inhibitor to drive selective WNT inhibition in TNKS1-deficient cell and organoid models. This work demonstrates a targetable cancer-specific vulnerability in multiple cancer types, providing a new approach for WNT-targeted therapies.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S8. B2M/MHCI/MHCII/PDL1-related HRS cell neighborhoods.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S8. B2M/MHCI/MHCII/PDL1-related HRS cell neighborhoods.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S8. Comparison of EBV-positive and EBV-negative cHL.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S8 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S8. Comparison of EBV-positive and EBV-negative cHL.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S9. Gene expression landscape of EBV-related cHL.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S9. Gene expression landscape of EBV-related cHL.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S12 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S12. HRS cell aggregates.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S12 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S12. HRS cell aggregates.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S2. Tracking of cell loss across staining cycles.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S2. Tracking of cell loss across staining cycles.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S10. Quantification of HRS cell patterns of spatial organization.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S10. Quantification of HRS cell patterns of spatial organization.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S5. Cell count, cell loss, and field of view count for each patient.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S5. Cell count, cell loss, and field of view count for each patient.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S1. Validation of mpIF antibody panel.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Figure S1. Validation of mpIF antibody panel.
- Open Access
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S6. Cell type counts for each patient.
- 3 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from Multiplexed Spatial Profiling of Hodgkin Reed–Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Supplementary Table S6. Cell type counts for each patient.